Chemed (CHE) Receivables (2009 - 2026)

Chemed (CHE) has reported Receivables for 18 consecutive years, with $215.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Receivables fell 25.03% year-over-year to $215.5 million; the TTM figure through Mar 2026 stood at $215.5 million (down 25.03% YoY), while the FY2025 annual figure was $191.2 million, up 6.26% from the prior year.
• Receivables came in at $215.5 million for Q1 2026 at Chemed, up from $191.2 million in the prior quarter.
• The five-year high for Receivables was $287.4 million in Q1 2025, with the low at $117.3 million in Q1 2022.
• Average Receivables over 5 years is $176.3 million, with a median of $180.0 million recorded in 2024.
• Across the five-year window, Receivables soared 60.22% in 2025 and fell 25.03% in 2026, its largest moves.
• Year by year, Receivables stood at $141.2 million in 2022, then rose by 29.7% to $183.2 million in 2023, then dropped by 1.76% to $180.0 million in 2024, then climbed by 6.26% to $191.2 million in 2025, then advanced by 12.68% to $215.5 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $215.5 million, $191.2 million, and $223.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.